VEGFR2 Monoclonal antibody

VEGFR2 Monoclonal Antibody for FC, WB,ELISA

Host / Isotype

Mouse / IgG1


Human and More (1)







Cat no : 67407-1-Ig


CD309, Fetal liver kinase 1, FLK 1, FLK1, KDR, Kinase insert domain receptor, VEGFR, VEGFR 2, VEGFR2

Tested Applications

Positive WB detected inhuman placenta tissue
Positive FC detected inHUVEC cells

Recommended dilution

Western Blot (WB)WB : 1:1000-1:8000
Sample-dependent, check data in validation data gallery

Published Applications

WBSee 2 publications below

Product Information

67407-1-Ig targets VEGFR2 in WB, FC,ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Cited Reactivityhuman
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen VEGFR2 fusion protein Ag24589
Full Name kinase insert domain receptor (a type III receptor tyrosine kinase)
Calculated molecular weight 1356 aa, 152 kDa
Observed molecular weight 230 kDa
GenBank accession numberBC131822
Gene symbol KDR
Gene ID (NCBI) 3791
Conjugate Unconjugated
Form Liquid
Purification Method Protein G purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Aliquoting is unnecessary for -20oC storage.

Background Information

KDR, also named as VEGFR-2, FLK1 and CD309, is a receptor for VEGF or VEGFC. KDR which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. KDR functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.


Product Specific Protocols
WB protocol for VEGFR2 antibody 67407-1-IgDownload protocol
FC protocol for VEGFR2 antibody 67407-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Front Genet

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.

Authors - Xiaofeng Dai

Front Oncol

An Essential NRP1-Mediated Role for Tagln2 in Gastric Cancer Angiogenesis.

Authors - Hongwei Jin